Functional properties of the HIV-1 long terminal repeat containing single-nucleotide polymorphisms in Sp site III and CCAAT/enhancer binding protein site i

Virology Journal

Volumn 11, Issue 1, 2014, Pages

  Shah, Sonia ^a   Alexaki, Aikaterini ^a   Pirrone, Vanessa ^a   Dahiya, Satinder ^a   Nonnemacher, Michael R ^a   Wigdahl, Brian ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

C EBP; HIV 1 genetics; Integration; Single nucleotide polymorphisms; Sp; Viral latency; Viral transcription

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN; CCAAT ENHANCER BINDING PROTEIN SITE I; GREEN FLUORESCENT PROTEIN; PROTEIN; SP SITE III; TRANSCRIPTION ELONGATION FACTOR; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG; PROTEIN BINDING; SP1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR SP1;

ARTICLE; BINDING SITE; BONE MARROW; CELL CLONE; CELL POPULATION; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; JURKAT CELL LINE; LONG TERMINAL REPEAT; MONOCYTE; NUCLEOTIDE SEQUENCE; PHENOTYPE; PLASMID; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; STEM CELL; T LYMPHOCYTE; U937 CELL LINE; VIRUS LATENCY; VIRUS REACTIVATION; WILD TYPE; CELL LINE; GEL MOBILITY SHIFT ASSAY; GENETICS; METABOLISM; PHYSIOLOGY; VIRUS ACTIVATION;

CCAAT-ENHANCER-BINDING PROTEINS; CELL LINE; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FLOW CYTOMETRY; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN BINDING; SP1 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC; VIRUS ACTIVATION;

EID: 84902143618     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-11-92     Document Type: Article

References (62)

1. Experimental approaches to the study of HIV-1 latency. Han Y, Wind-Rotolo M, Yang HC, Siliciano JD, Siliciano RF, Nat Rev Microbiol 2007 5 95 106 10.1038/nrmicro1580 17224919
2. Latency: the hidden HIV-1 challenge. Marcello A, Retrovirology 2006 3 7 10.1186/1742-4690-3-7 16412247
3. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M, Nature 1995 373 123 126 10.1038/373123a0 7816094
4. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Zack JA, Arrigo SJ, Weitsman SR, Go AS, Haislip A, Chen IS, Cell 1990 61 213 222 10.1016/0092-8674(90)90802-L 2331748
5. Mononuclear phagocytes of blood and bone marrow: comparative roles as viral reservoirs in human immunodeficiency virus type 1 infections. McElrath MJ, Pruett JE, Cohn ZA, Proc Natl Acad Sci U S A 1989 86 675 679 10.1073/pnas.86.2.675 2492110
6. Cytokine regulation of HIV replication induced by dendritic cell-CD4-positive T cell interactions. Weissman D, Daucher J, Barker T, Adelsberger J, Baseler M, Fauci AS, AIDS Res Hum Retroviruses 1996 12 759 767 10.1089/aid.1996.12.759 8738427
7. Active nuclear import of human immunodeficiency virus type 1 preintegration complexes. Bukrinsky MI, Sharova N, Dempsey MP, Stanwick TL, Bukrinskaya AG, Haggerty S, Stevenson M, Proc Natl Acad Sci U S A 1992 89 6580 6584 10.1073/pnas.89.14.6580 1631159
8. Characterization of a promonocyte clone chronically infected with HIV and inducible by 13-phorbol-12-myristate acetate. Folks TM, Justement J, Kinter A, Schnittman S, Orenstein J, Poli G, Fauci AS, J Immunol 1988 140 1117 1122 2449497
9. HIV-2 transmission: implications for spread of HIV-1. O'Brien TR, JAMA 1994 271 903 904 10.1001/jama.1994.03510360027021
10. Macrophage tropism of HIV-1 depends on efficient cellular dNTP utilization by reverse transcriptase. Diamond TL, Roshal M, Jamburuthugoda VK, Reynolds HM, Merriam AR, Lee KY, Balakrishnan M, Bambara RA, Planelles V, Dewhurst S, Kim B, J Biol Chem 2004 279 51545 51553 10.1074/jbc.M408573200 15452123
11. In vitro infection of human monocytes with human T lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). Nicholson JK, Cross GD, Callaway CS, McDougal JS, J Immunol 1986 137 323 329 3011909
12. Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome. Ho DD, Rota TR, Schooley RT, Kaplan JC, Allan JD, Groopman JE, Resnick L, Felsenstein D, Andrews CA, Hirsch MS, N Engl J Med 1985 313 1493 1497 10.1056/NEJM198512123132401 2999591
13. Innate and adaptive factors regulating human immunodeficiency virus type 1 genomic activation. Shah S, Nonnemacher MR, Pirrone V, Wigdahl B, J Neuroimmune Pharmacol 2010 5 278 293 10.1007/s11481-010-9207-x 20387125
14. Breaking down the barrier: the effects of HIV-1 on the blood-brain barrier. Strazza M, Pirrone V, Wigdahl B, Nonnemacher MR, Brain Res 2011 1399 96 115 21641584
15. Macrophage/microglial accumulation and proliferating cell nuclear antigen expression in the central nervous system in human immunodeficiency virus encephalopathy. Fischer-Smith T, Croul S, Adeniyi A, Rybicka K, Morgello S, Khalili K, Rappaport J, Am J Pathol 2004 164 2089 2099 10.1016/S0002-9440(10) 63767-4 15161643
16. Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Glass JD, Fedor H, Wesselingh SL, McArthur JC, Ann Neurol 1995 38 755 762 10.1002/ana.410380510 7486867
17. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Coffin JM, Science 1995 267 483 489 10.1126/science.7824947 7824947
18. The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin. Gao F, Robertson DL, Morrison SG, Hui H, Craig S, Decker J, Fultz PN, Girard M, Shaw GM, Hahn BH, Sharp PM, J Virol 1996 70 7013 7029 8794346
19. Development of co-selected single nucleotide polymorphisms in the viral promoter precedes the onset of human immunodeficiency virus type 1-associated neurocognitive impairment. Li L, Aiamkitsumrit B, Pirrone V, Nonnemacher MR, Wojno A, Passic S, Flaig K, Kilareski E, Blakey B, Ku J, Parikh N, Shah R, Martin-Garcia J, Moldover B, Servance L, Downie D, Lewis S, Jacobson JM, Kolson D, Wigdahl B, Journal of neurovirology 2011 17 92 109 10.1007/s13365-010-0014-1 21225391
20. Functional roles for the TATA promoter and enhancers in basal and Tat-induced expression of the human immunodeficiency virus type 1 long terminal repeat. Berkhout B, Jeang KT, J Virol 1992 66 139 149 1727476
21. Lain de Lera T, Soriano V, Alcami J, Lederman MM, Domingo E: LTR and tat variability of HIV-1 isolates from patients with divergent rates of disease progression. Quinones-Mateu ME, Mas A, Virus Res 1998 57 11 20 10.1016/S0168-1702(98)00082-3 9833881
22. Direct binding to nucleic acids by Vpr of human immunodeficiency virus type 1. Zhang S, Pointer D, Singer G, Feng Y, Park K, Zhao LJ, Gene 1998 212 157 166 10.1016/S0378-1119(98)00178-4 9611258
23. Specific sequence configurations of HIV-1 LTR G/C box array result in altered recruitment of Sp isoforms and correlate with disease progression. Nonnemacher MR, Irish BP, Liu Y, Mauger D, Wigdahl B, J Neuroimmunol 2004 157 39 47 10.1016/j.jneuroim.2004.08.021 15579278
24. Region-specific distribution of human immunodeficiency virus type 1 long terminal repeats containing specific configurations of CCAAT/enhancer-binding protein site II in brains derived from demented and nondemented patients. Burdo TH, Gartner S, Mauger D, Wigdahl B, J Neurovirol 2004 10 Suppl 1 7 14 14982733
25. High-affinity interaction between HIV-1 Vpr and specific sequences that span the C/EBP and adjacent NF-kappaB sites within the HIV-1 LTR correlate with HIV-1-associated dementia. Burdo TH, Nonnemacher M, Irish BP, Choi CH, Krebs FC, Gartner S, Wigdahl B, DNA Cell Biol 2004 23 261 269 10.1089/104454904773819842 15142383
26. HIV-1 LTR C/EBP binding site sequence configurations preferentially encountered in brain lead to enhanced C/EBP factor binding and increased LTR-specific activity. Ross HL, Gartner S, McArthur JC, Corboy JR, McAllister JJ, Millhouse S, Wigdahl B, J Neurovirol 2001 7 235 249 10.1080/ 13550280152403281 11517398
27. Interaction between CCAAT/enhancer binding protein and cyclic AMP response element binding protein 1 regulates human immunodeficiency virus type 1 transcription in cells of the monocyte/macrophage lineage. Ross HL, Nonnemacher MR, Hogan TH, Quiterio SJ, Henderson A, McAllister JJ, Krebs FC, Wigdahl B, J Virol 2001 75 1842 1856 10.1128/JVI.75.4.1842-1856.2001 11160683
28. Riddell Jt, Bixby D, Savona MR, Collins KL: HIV-1 infects multipotent progenitor cells causing cell death and establishing latent cellular reservoirs. Carter CC, Onafuwa-Nuga A, McNamara LA, Nat Med 2010 16 446 451 10.1038/nm.2109 20208541
29. Control of stochastic gene expression by host factors at the HIV promoter. Burnett JC, Miller-Jensen K, Shah PS, Arkin AP, Schaffer DV, PLoS Pathog 2009 5 1000260 10.1371/journal.ppat.1000260 19132086
30. The site of HIV-1 integration in the human genome determines basal transcriptional activity and response to Tat transactivation. Jordan A, Defechereux P, Verdin E, EMBO J 2001 20 1726 1738 10.1093/emboj/20.7.1726 11285236
31. Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences. Mitchell RS, Beitzel BF, Schroder AR, Shinn P, Chen H, Berry CC, Ecker JR, Bushman FD, PLoS Biol 2004 2 234 10.1371/journal.pbio.0020234 15314653
32. Stochastic gene expression in a lentiviral positive-feedback loop: HIV-1 Tat fluctuations drive phenotypic diversity. Weinberger LS, Burnett JC, Toettcher JE, Arkin AP, Schaffer DV, Cell 2005 122 169 182 10.1016/j.cell.2005. 06.006 16051143
33. HIV-1 integration in the human genome favors active genes and local hotspots. Schroder AR, Shinn P, Chen H, Berry C, Ecker JR, Bushman F, Cell 2002 110 521 529 10.1016/S0092-8674(02)00864-4 12202041
34. Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS. Koot M, Keet IP, Vos AH, De Goede RE, Roos MT, Coutinho RA, Miedema F, Schellekens PT, Tersmette M, Ann Intern Med 1993 118 681 688 10.7326/0003-4819-118-9-199305010-00004 8096374
35. Biological properties of HIV isolates in primary HIV infection: consequences for the subsequent course of infection. Nielsen C, Pedersen C, Lundgren JD, Gerstoft J, AIDS 1993 7 1035 1040 10.1097/00002030-199308000-00002 8104421
36. Expression directed from HIV long terminal repeats in the central nervous system of transgenic mice. Corboy JR, Buzy JM, Zink MC, Clements JE, Science 1992 258 1804 1808 10.1126/science.1465618 1465618
37. Structural and functional evolution of human immunodeficiency virus type 1 long terminal repeat CCAAT/enhancer binding protein sites and their use as molecular markers for central nervous system disease progression. Hogan TH, Stauff DL, Krebs FC, Gartner S, Quiterio SJ, Wigdahl B, J Neurovirol 2003 9 55 68 10.1080/13550280390173292 12587069
38. HIV-1 Vpr binding to HIV-1 LTR C/EBP cis-acting elements and adjacent regions is sequence-specific. Hogan TH, Nonnemacher MR, Krebs FC, Henderson A, Wigdahl B, Biomed Pharmacothe 2003 57 41 48
39. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication. McAllister JJ, Phillips D, Millhouse S, Conner J, Hogan T, Ross HL, Wigdahl B, Virology 2000 274 262 277 10.1006/viro.2000.0476 10964770
40. TAR-independent activation of the HIV-1 LTR: evidence that tat requires specific regions of the promoter. Berkhout B, Gatignol A, Rabson AB, Jeang KT, Cell 1990 62 757 767 10.1016/0092-8674(90)90120-4 2201451
41. TAR independent activation of the human immunodeficiency virus in phorbol ester stimulated T lymphocytes. Harrich D, Garcia J, Mitsuyasu R, Gaynor R, EMBO J 1990 9 4417 4423 2124973
42. The hepatitis B virus X protein induces HIV-1 replication and transcription in synergy with T-cell activation signals: functional roles of NF-kappaB/NF-AT and SP1-binding sites in the HIV-1 long terminal repeat promoter. Gomez-Gonzalo M, Carretero M, Rullas J, Lara-Pezzi E, Aramburu J, Berkhout B, Alcami J, Lopez-Cabrera M, J Biol Chem 2001 276 35435 35443 10.1074/jbc.M103020200 11457829
43. The NF-kappa B binding sites in the human immunodeficiency virus type 1 long terminal repeat are not required for virus infectivity. Leonard J, Parrott C, Buckler-White AJ, Turner W, Ross EK, Martin MA, Rabson AB, J Virol 1989 63 4919 4924 2795721
44. Contribution of NF-kappa B and Sp1 binding motifs to the replicative capacity of human immunodeficiency virus type 1: distinct patterns of viral growth are determined by T-cell types. Ross EK, Buckler-White AJ, Rabson AB, Englund G, Martin MA, J Virol 1991 65 4350 4358 2072454
45. Regulation of HIV-1 transcription in cells of the monocyte-macrophage lineage. Kilareski EM, Shah S, Nonnemacher MR, Wigdahl B, Retrovirology 2009 6 118 10.1186/1742-4690-6-118 20030845
46. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Choe H, Farzan M, Sun Y, Sullivan N, Rollins B, Ponath PD, Wu L, Mackay CR, LaRosa G, Newman W, Gerard N, Gerard C, Sodroski J, Cell 1996 85 1135 1148 10.1016/S0092-8674(00)81313-6 8674119
47. Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule. Fouchier RA, Groenink M, Kootstra NA, Tersmette M, Huisman HG, Miedema F, Schuitemaker H, J Virol 1992 66 3183 3187 1560543
48. Genotypic and phenotypic characterization of HIV-1 patients with primary infection. Zhu T, Mo H, Wang N, Nam DS, Cao Y, Koup RA, Ho DD, Science 1993 261 1179 1181 10.1126/science.8356453 8356453
49. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Griffin WS, Stanley LC, Ling C, White L, MacLeod V, Perrot LJ, White CL 3rd, Araoz C, Proc Natl Acad Sci U S A 1989 86 7611 7615 10.1073/pnas.86.19.7611 2529544
50. Regulation of expression of the interleukin 6 gene: structure and function of the transcription factor NF-IL6. Akira S, Isshiki H, Nakajima T, Kinoshita S, Nishio Y, Natsuka S, Kishimoto T, Ciba Found Symp 1992 167 47 62 discussion 62-47 1385054
51. The p50 subunit of NF-kappa B associates with the NF-IL6 transcription factor. LeClair KP, Blanar MA, Sharp PA, Proc Natl Acad Sci U S A 1992 89 8145 8149 10.1073/pnas.89.17.8145 1518839
52. C/EBP proteins activate transcription from the human immunodeficiency virus type 1 long terminal repeat in macrophages/monocytes. Henderson AJ, Zou X, Calame KL, J Virol 1995 69 5337 5344 7636977
53. Increased viral burden and cytopathicity correlate temporally with CD4+ T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals. Connor RI, Mohri H, Cao Y, Ho DD, J Virol 1993 67 1772 1777 8095306
54. Variable role of the long terminal repeat Sp1-binding sites in human immunodeficiency virus replication in T lymphocytes. Parrott C, Seidner T, Duh E, Leonard J, Theodore TS, Buckler-White A, Martin MA, Rabson AB, J Virol 1991 65 1414 1419 1995951
55. Naturally occurring genotypes of the human immunodeficiency virus type 1 long terminal repeat display a wide range of basal and Tat-induced transcriptional activities. Michael NL, D'Arcy L, Ehrenberg PK, Redfield RR, J Virol 1994 68 3163 3174 7908701
56. Human immunodeficiency virus type 1 long terminal repeat variants from 42 patients representing all stages of infection display a wide range of sequence polymorphism and transcription activity. Estable MC, Bell B, Merzouki A, Montaner JS, O'Shaughnessy MV, Sadowski IJ, J Virol 1996 70 4053 4062 8648743
57. Activity of human immunodeficiency virus type 1 promoter/TAR regions and tat1 genes derived from individuals with different rates of disease progression. Kirchhoff F, Greenough TC, Hamacher M, Sullivan JL, Desrosiers RC, Virology 1997 232 319 331 10.1006/viro.1997.8586 9191845
58. Cell culture and passaging alters gene expression pattern and proliferation rate in rheumatoid arthritis synovial fibroblasts. Neumann E, Riepl B, Knedla A, Lefevre S, Tarner IH, Grifka J, Steinmeyer J, Scholmerich J, Gay S, Muller-Ladner U, Arthritis Res Ther 2010 12 83 10.1186/ar3010 20462438
59. PMA-induced differentiation of a bone marrow progenitor cell line activates HIV-1 LTR-driven transcription. Alexaki A, Quiterio SJ, Liu Y, Irish B, Kilareski E, Nonnemacher MR, Wigdahl B, DNA Cell Biol 2007 26 387 394 10.1089/dna.2006.0542 17570762
60. Krebs FC, Hogan TH, Quiterio S, Gartner S, Wigdahl B, Lentiviral LTR-directed expression, sequence variation, and disease pathogenesis Los Alamos National Laboratory HIV Sequence: Compendium 2002
61. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Dignam JD, Lebovitz RM, Roeder RG, Nucleic Acids Res 1983 11 1475 1489 10.1093/nar/11.5.1475 6828386
62. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Bradford MM, Anal Biochem 1976 72 248 254 10.1016/0003-2697(76)90527-3 942051